Each vial contains highly pure lyophilized Retatrutide.
Retatrutide is classified as a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors), making it more effective for body fat mass reduction than its predecessors Tirzepatide and Semaglutide by targeting further receptors. Unlike Wegovy (GLP-1) or Mounjaro (GIP/GLP-1), Retatrutide is the first to add a Glucagon agonist, actively increasing energy expenditure and fat metabolism, not just suppressing appetite.
Unauthorized health products have not been approved by Health Canada and may pose serious health risks. They can contain unsafe or undisclosed ingredients, incorrect dosages, and may interact with other medications. Prescription drugs should only be used under medical supervision and are legally sold in Canada only with a valid prescription.
Each vial contains highly pure lyophilized Retatrutide.
Retatrutide is classified as a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors), making it more effective for body fat mass reduction than its predecessors Tirzepatide and Semaglutide by targeting further receptors. Unlike Wegovy (GLP-1) or Mounjaro (GIP/GLP-1), Retatrutide is the first to add a Glucagon agonist, actively increasing energy expenditure and fat metabolism, not just suppressing appetite.
Unauthorized health products have not been approved by Health Canada and may pose serious health risks. They can contain unsafe or undisclosed ingredients, incorrect dosages, and may interact with other medications. Prescription drugs should only be used under medical supervision and are legally sold in Canada only with a valid prescription.